4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine, 95.0%, 5g

Analytical balance Models ABS-N series, external calibration, 120 g, ABS 120-4N (W)

7-Fluoro-N,N-dimethylbenzo[c][1,2,5]oxadiazole-4-sulfonamide, 97%, 100mg

(S)-2-Amino-4,4-difluorobutanoic acid, 95%, 50mg

2-(9,9'-Spirobi[fluoren]-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(HPLC)(T)5g

(S)-N-Cbz-3-Hydroxypyrrolidine, 95.0%, 100g

1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid, 95.0%, 25g

(R)-5-Benzyl-2-phenyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium tetrafluoroborate, 97%, 5g

1-(2-Bromo-ethoxy)-3-methyl-benzene, 95%, 5g

((3H-[1,2,3]Triazolo[4,5-b]pyridin-3-yl)oxy)tris(dimethylamino)phosphonium hexafluorophosphate(V), 95.0%, 1g

2-Phenyl-3-methylimidazo[1,2-b]thiazole, 1g

2-(1h-Imidazol-1-yl)benzenesulfonamide, 97%, 1g

(2,4-Dioxo-thiazolidin-5-yl)-acetic acid, 95.0%, 1g